BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24575291)

  • 1. Current understanding in diagnosis and management of factor XIII deficiency.
    Naderi M; Dorgalaleh A; Tabibian Sh; Alizadeh Sh; Eshghi P; Solaimani G
    Iran J Ped Hematol Oncol; 2013; 3(4):164-72. PubMed ID: 24575291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial hemorrhage in congenital deficiency of factor XIII.
    Abbondanzo SL; Gootenberg JE; Lofts RS; McPherson RA
    Am J Pediatr Hematol Oncol; 1988; 10(1):65-8. PubMed ID: 3189718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.
    Dorgalaleh A; Tabibian S; Assadollahi V; Shamsizadeh M; Zareban I; Soori S; Daneshi M
    Lab Med; 2016 Nov; 47(4):283-285. PubMed ID: 27522062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital factor XIII deficiency: report of a case and literature review.
    Laosombat V; Maipang M; Wongchanchailert M
    J Med Assoc Thai; 1989 Dec; 72(12):701-7. PubMed ID: 2697742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired autoimmune coagulation factor XIII/13 deficiency].
    Ogawa Y
    Rinsho Ketsueki; 2020; 61(7):799-808. PubMed ID: 32759568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic factor XIII deficiency with normal urea solubility test.
    Sanfelippo MJ; Mazza JJ; Mercier RJ
    Clin Lab; 2014; 60(12):2099-102. PubMed ID: 25651747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the art in factor XIII laboratory assessment.
    Durda MA; Wolberg AS; Kerlin BA
    Transfus Apher Sci; 2018 Dec; 57(6):700-704. PubMed ID: 30087086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
    Biswas A; Ivaskevicius V; Thomas A; Oldenburg J
    Hamostaseologie; 2014; 34(2):160-6. PubMed ID: 24503678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor XIII : Pharmacodynamic and pharmacokinetic characteristics].
    Adam EH; Kreuer S; Zacharowski K; Weber CF; Wildenauer R
    Anaesthesist; 2017 Jan; 66(1):52-59. PubMed ID: 27942785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII.
    Kitchens CS; Newcomb TF
    Medicine (Baltimore); 1979 Nov; 58(6):413-29. PubMed ID: 514066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII deficiency presenting with intracerebral bleed.
    Sawlani KK; Chaudhary SC; Roy A; Tripathi AK
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23314446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory features of congenital factor XIII deficiency.
    Al-Sharif FZ; Aljurf MD; Al-Momen AM; Ajlan AM; Musa MO; Al-Nounou RM; Al-Mohareb FI; Alomar HM; Zaidi ZZ; Al-Zahrani HA
    Saudi Med J; 2002 May; 23(5):552-4. PubMed ID: 12070580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
    Tahlan A; Ahluwalia J
    Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII deficiency.
    Hsieh L; Nugent D
    Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.